These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21985818)

  • 1. How do health care providers deal with kala-azar in the Indian subcontinent?
    Kumar N; Singh SP; Mondal D; Joshi A; Das P; Sundar S; Kroeger A; Hirve S; Siddiqui NA; Boelaert M
    Indian J Med Res; 2011 Sep; 134(3):349-55. PubMed ID: 21985818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.
    Mondal D; Singh SP; Kumar N; Joshi A; Sundar S; Das P; Siddhivinayak H; Kroeger A; Boelaert M
    PLoS Negl Trop Dis; 2009; 3(1):e355. PubMed ID: 19159009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of Kala-Azar from the Southeast Asia Region.
    Bhattacharya SK; Dash AP
    Am J Trop Med Hyg; 2017 Apr; 96(4):802-804. PubMed ID: 28115678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs.
    Huda MM; Hirve S; Siddiqui NA; Malaviya P; Banjara MR; Das P; Kansal S; Gurung CK; Naznin E; Rijal S; Arana B; Kroeger A; Mondal D
    BMC Public Health; 2012 Nov; 12():1001. PubMed ID: 23164318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.
    Banjara MR; Kroeger A; Huda MM; Kumar V; Gurung CK; Das ML; Rijal S; Das P; Mondal D
    Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):408-15. PubMed ID: 25918216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of vector characteristics of Phlebotomus argentipes in the kala-azar elimination programme in the Indian sub-continent.
    Chowdhury R; Kumar V; Mondal D; Das ML; Das P; Dash AP; Kroeger A
    Pathog Glob Health; 2016 May; 110(3):87-96. PubMed ID: 27376500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal.
    Joshi AB; Das ML; Akhter S; Chowdhury R; Mondal D; Kumar V; Das P; Kroeger A; Boelaert M; Petzold M
    BMC Med; 2009 Oct; 7():54. PubMed ID: 19804620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region.
    Karunaweera ND; Ferreira MU
    Parasitology; 2018 Apr; 145(4):425-429. PubMed ID: 29642962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnitude of unreported kala-azar cases in a highly endemic district of Bihar, India: A positive impact of Indian elimination programme.
    Siddiqui NA; Pandey K; R Das VN; Sinha SK; Verma RB; Lal CS; Ali V; Topno RK; Dikhit MR; Das P
    J Vector Borne Dis; 2019; 56(4):315-322. PubMed ID: 33269731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment.
    Sundar S; Mondal D; Rijal S; Bhattacharya S; Ghalib H; Kroeger A; Boelaert M; Desjeux P; Richter-Airijoki H; Harms G
    Trop Med Int Health; 2008 Jan; 13(1):2-5. PubMed ID: 18290995
    [No Abstract]   [Full Text] [Related]  

  • 11. A cost benefit analysis of elimination of kala-azar in Indian subcontinent: an example of Nepal.
    Adhikari SR; Supakankunti S
    J Vector Borne Dis; 2010 Sep; 47(3):127-39. PubMed ID: 20834081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Present situation of vector-control management in Bangladesh: a wake up call.
    Mondal D; Alam MS; Karim Z; Haque R; Boelaert M; Kroeger A
    Health Policy; 2008 Sep; 87(3):369-76. PubMed ID: 18342389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data.
    Chowdhury R; Mondal D; Chowdhury V; Faria S; Alvar J; Nabi SG; Boelaert M; Dash AP
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3020. PubMed ID: 25144317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Hematological Features of Visceral Leishmaniasis at Mymensingh Medical College Hospital.
    Malek MS; Robi IH; Islam MS; Kabir MA; Uddin MZ; Sumon SM; Siddiqui NI
    Mymensingh Med J; 2020 Oct; 29(4):879-886. PubMed ID: 33116091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kala-azar elimination in a highly-endemic district of Bihar, India: A success story.
    Kumar V; Mandal R; Das S; Kesari S; Dinesh DS; Pandey K; Das VR; Topno RK; Sharma MP; Dasgupta RK; Das P
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008254. PubMed ID: 32365060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent.
    Medley GF; Hollingsworth TD; Olliaro PL; Adams ER
    Nature; 2015 Dec; 528(7580):S102-8. PubMed ID: 26633763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.
    Hirve S; Singh SP; Kumar N; Banjara MR; Das P; Sundar S; Rijal S; Joshi A; Kroeger A; Varghese B; Thakur CP; Huda MM; Mondal D
    Am J Trop Med Hyg; 2010 Sep; 83(3):507-11. PubMed ID: 20810811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.
    Bern C; Chowdhury R
    Indian J Med Res; 2006 Mar; 123(3):275-88. PubMed ID: 16778310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era.
    Garlapati R; Iniguez E; Serafim TD; Mishra PK; Rooj B; Sinha B; Valenzuela JG; Srikantiah S; Bern C; Kamhawi S
    Front Cell Infect Microbiol; 2021; 11():641632. PubMed ID: 33768013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Knowledge, Attitudes, and Practices toward Kala-azar in an Endemic District in Bangladesh: A Cross-Sectional Survey.
    Faria S; Hossain SM; Islam MS; Chowdhury V; Chowdhury R
    Am J Trop Med Hyg; 2023 Apr; 108(4):783-790. PubMed ID: 36878211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.